[company_age]5.0[/company_age][employees]11-50 employees[/employees][funding]Series A[/funding][description]MimiX Biotherapeutics is a Swiss biomedical company pioneering a revolutionary biofabrication technology called Sound Induced Morphogenesis (SIM). SIM mimics nature's design to aggregate and pattern biologicals by tuning sound profiles, resulting in morphologically induced tissue generation. This contactless, fast, and delicate process sets MimiX apart from traditional biofabrication methods. The company's unique acoustic biofabrication solution, cymatiX®, makes SIM technology accessible to the scientific and clinical community. MimiX is dedicated to extending the boundaries of biofabrication and making bioengineered, artificial human organs and tissues a reality. This focus on personalized medicine solutions, such as FastSkin® autologous tissue for complex wound care, distinguishes MimiX from competitors.[/description][ps]Sound Induced Morphogenesis (SIM) technology, cymatiX® acoustic biofabrication solution, FastSkin® autologous tissue for complex wound care.[/ps]